Johan Botling

13.9k total citations · 1 hit paper
117 papers, 5.3k citations indexed

About

Johan Botling is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Johan Botling has authored 117 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Oncology, 45 papers in Molecular Biology and 35 papers in Cancer Research. Recurrent topics in Johan Botling's work include Cancer Genomics and Diagnostics (26 papers), Lung Cancer Treatments and Mutations (26 papers) and Cancer Immunotherapy and Biomarkers (18 papers). Johan Botling is often cited by papers focused on Cancer Genomics and Diagnostics (26 papers), Lung Cancer Treatments and Mutations (26 papers) and Cancer Immunotherapy and Biomarkers (18 papers). Johan Botling collaborates with scholars based in Sweden, Germany and United Kingdom. Johan Botling's co-authors include Patrick Micke, Karolina Edlund, Carolina Wählby, Mats Nilsson, Marco Mignardi, Alexandra Pacureanu, Jessica Svedlund, Rongqin Ke, Kenneth Nilsson and Fredrik Öberg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Johan Botling

111 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

In situ sequencing for RNA analysis in preserved tissue and cells

2013 617 citations Johan Botling et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Johan Botling Sweden	39	2.8k	1.6k	1.2k	1.1k	1.1k	117	5.3k
Qianxing Mo United States	39	3.2k 1.2×	1.8k 1.1×	1.0k 0.8×	933 0.9×	845 0.8×	138	6.2k
Lalita A. Shevde United States	41	4.5k 1.6×	2.5k 1.6×	1.6k 1.3×	1.0k 1.0×	1.3k 1.2×	105	6.9k
Jaime Rodriguez‐Canales United States	44	2.7k 1.0×	2.9k 1.8×	1.7k 1.4×	1.3k 1.2×	1.3k 1.2×	163	6.8k
Trevor J. Pugh Canada	34	2.8k 1.0×	1.4k 0.9×	1.3k 1.0×	700 0.6×	857 0.8×	149	5.0k
Vladimir Lazar France	46	4.1k 1.5×	2.1k 1.3×	2.1k 1.7×	954 0.9×	974 0.9×	133	7.4k
Michael S. Khodadoust United States	23	3.2k 1.1×	2.0k 1.3×	1.5k 1.3×	1.8k 1.7×	2.0k 1.9×	93	6.3k
Yun Wu United States	36	2.1k 0.7×	2.5k 1.5×	1.8k 1.4×	870 0.8×	728 0.7×	105	5.2k
Boris Pasche United States	40	3.0k 1.1×	2.1k 1.3×	1.2k 1.0×	793 0.7×	542 0.5×	122	5.9k
Melissa R. Junttila United States	30	3.9k 1.4×	3.0k 1.8×	1.4k 1.2×	738 0.7×	1.4k 1.4×	53	7.1k
Efstathios N. Stathopoulos Greece	38	1.9k 0.7×	1.9k 1.2×	1.5k 1.2×	1.1k 1.1×	806 0.8×	118	4.9k

Countries citing papers authored by Johan Botling

Since Specialization

Citations

This map shows the geographic impact of Johan Botling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Botling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Botling more than expected).

Fields of papers citing papers by Johan Botling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan Botling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Botling. The network helps show where Johan Botling may publish in the future.

Co-authorship network of co-authors of Johan Botling

This figure shows the co-authorship network connecting the top 25 collaborators of Johan Botling. A scholar is included among the top collaborators of Johan Botling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johan Botling. Johan Botling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Botling, Johan, Britt Skogseid, Barbro Eriksson, et al.. (2025). The impact of re‐characterizing metastatic pancreatic neuroendocrine tumors: A prospective study. Journal of Neuroendocrinology. 37(8). e70040–e70040. 2 indexed citations

Cai, Curtis, Daniela Nascimento Silva, Ola B. Nilsson, et al.. (2025). Unlocking novel T cell-based immunotherapy for hepatocellular carcinoma through neoantigen-driven T cell receptor isolation. Gut. 74(7). 1125–1136.

Imgenberg‐Kreuz, Juliana, et al.. (2023). Utilizing CD44v6 and V600EBRAF-mutation for in vitro targeted combination therapy of thyroid carcinomas. Heliyon. 9(12). e22594–e22594. 4 indexed citations

Viðarsdóttir, Halla, Karin Jirström, Björn Nodin, et al.. (2023). Diagnostic gastrointestinal markers in primary lung cancer and pulmonary metastases. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 485(2). 347–357. 2 indexed citations

Pellinen, Teijo, Lassi Paavolainen, Carina Strell, et al.. (2022). Fibroblast subsets in non-small cell lung cancer: Associations with survival, mutations, and immune features. JNCI Journal of the National Cancer Institute. 115(1). 71–82. 38 indexed citations

Micke, Patrick, Johanna Sofia Margareta Mattsson, Linnéa La Fleur, et al.. (2020). Comprehensive analysis of RNA binding motif protein 3 (RBM3) in non‐small cell lung cancer. Cancer Medicine. 9(15). 5609–5619. 9 indexed citations

Fleur, Linnéa La, Johan Botling, Fei He, et al.. (2020). Targeting MARCO and IL37R on Immunosuppressive Macrophages in Lung Cancer Blocks Regulatory T Cells and Supports Cytotoxic Lymphocyte Function. Cancer Research. 81(4). 956–967. 168 indexed citations

Evren, Elza, Emma Ringqvist, Kumar Parijat Tripathi, et al.. (2020). Distinct developmental pathways from blood monocytes generate human lung macrophage diversity. Immunity. 54(2). 259–275.e7. 113 indexed citations

Kroeze, Leonie I., Richarda M. de Voer, Eveline J. Kamping, et al.. (2020). Evaluation of a Hybrid Capture–Based Pan-Cancer Panel for Analysis of Treatment Stratifying Oncogenic Aberrations and Processes. Journal of Molecular Diagnostics. 22(6). 757–769. 43 indexed citations

10.

Tsakonas, Georgios, Johan Botling, Patrick Micke, et al.. (2019). c-MET as a biomarker in patients with surgically resected non-small cell lung cancer. Lung Cancer. 133. 69–74. 24 indexed citations

11.

Micke, Patrick, Johan Botling, Johanna Sofia Margareta Mattsson, et al.. (2019). Mucin staining is of limited value in addition to basic immunohistochemical analyses in the diagnostics of non-small cell lung cancer. Scientific Reports. 9(1). 1319–1319. 7 indexed citations

12.

Micke, Patrick, Johanna Sofia Margareta Mattsson, Dijana Djureinovic, et al.. (2016). The Impact of the Fourth Edition of the WHO Classification of Lung Tumours on Histological Classification of Resected Pulmonary NSCCs. Journal of Thoracic Oncology. 11(6). 862–872. 58 indexed citations

13.

Karlsson, Anna, Markus Ringnér, Martin Lauss, et al.. (2014). Genomic and Transcriptional Alterations in Lung Adenocarcinoma in Relation to Smoking History. Clinical Cancer Research. 20(18). 4912–4924. 23 indexed citations

14.

Noguchi, Satoshi, Akira Saito, Masafumi Horie, et al.. (2014). An Integrative Analysis of the Tumorigenic Role of TAZ in Human Non–Small Cell Lung Cancer. Clinical Cancer Research. 20(17). 4660–4672. 77 indexed citations

15.

Leuchowius, Karl‐Johan, Carl-Magnus Clausson, Karin Grannas, et al.. (2013). Parallel Visualization of Multiple Protein Complexes in Individual Cells in Tumor Tissue. Molecular & Cellular Proteomics. 12(6). 1563–1571. 44 indexed citations

16.

Botling, Johan, Karolina Edlund, Miriam Lohr, et al.. (2012). Biomarker Discovery in Non–Small Cell Lung Cancer: Integrating Gene Expression Profiling, Meta-analysis, and Tissue Microarray Validation. Clinical Cancer Research. 19(1). 194–204. 284 indexed citations

17.

Tugues, Sònia, Satoshi Honjo, Christian König, et al.. (2012). Genetic Deficiency in Plasma Protein HRG Enhances Tumor Growth and Metastasis by Exacerbating Immune Escape and Vessel Abnormalization. Cancer Research. 72(8). 1953–1963. 36 indexed citations

18.

Hallett, Michael, Hilde Johnsen, Kristine Kleivi Sahlberg, et al.. (2010). Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer. Molecular Oncology. 4(4). 357–368. 91 indexed citations

19.

Micke, Patrick, Janna Paulsson, Martin Augsten, et al.. (2010). Forkhead Box F1 Regulates Tumor-Promoting Properties of Cancer-Associated Fibroblasts in Lung Cancer. Cancer Research. 70(7). 2644–2654. 88 indexed citations

20.

Micke, Patrick, Kai Kappert, Mitsuhiro Ohshima, et al.. (2007). In Situ Identification of Genes Regulated Specifically in Fibroblasts of Human Basal Cell Carcinoma. Journal of Investigative Dermatology. 127(6). 1516–1523. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact